Search results
Found 22830 matches for
Athena Swan Award Ceremony
10 June 2013
Liz Barnes-Moss, Departmental Administrator, was presented with NDCN's Athena Swan Bronze Award by Dame Julia Higgins at a ceremony held at the Royal Society in Edinburgh on June 6th.
New Action Research Professor of Clinical Neurology Announced
15 February 2013
Professor Peter Rothwell FMedSci has been appointed the new Action Research Professor of Clinical Neurology in the Nuffield Department of Clinical Neurosciences, succeeding Professor George Ebers.
New stem cell approach for blindness successful in mice
15 January 2013
Blind mice can see again, after Oxford University researchers transplanted developing cells into their eyes and found they could re-form the entire light-sensitive layer of the retina.
New Genetic Disorder Discovered by NDCN Team
11 January 2013
The family of disorders known as ataxias can impair speech, balance and coordination, and have varying levels of severity. A team led by Dr Andrea Nemeth from NDCN has identified a new member of this group of conditions which is connected to Spinocerebellar Ataxia Type 5 (SCA5). SCA5 is sometimes known as ‘Lincoln ataxia,’ because it was first found in the relatives of US President Abraham Lincoln.
Studentship in MRI Physics
5 December 2012
The FMRIB Physics Group is advertising a competitive graduate studentship for Oct 2013 entry.
Stem cells for Biological Assays of Novel drugs and predictive toxiCology (StemBANCC)
3 December 2012
Oxford University has recently led a successful bid to establish a €52M international consortium to develop induced pluripotent stem (iPS) cell lines for drug discovery and safety assessment.
UK Biobank Imaging Extension Approved
1 October 2012
UK Biobank is an on-going prospective epidemiological study that has already collected genetics, blood, lifestyle information and other data from a cohort of 500,000 subjects, to be followed over coming decades. The "UK Biobank Imaging Extension", which aims to bring back 100,000 of the cohort for multimodal neuroimaging and cardiac MRI (amongst other measures), has just been given the go-ahead. This will be by far the largest neuro/cardiac imaging study carried out to date, and will add very rich phenotyping to the project.
New Member of Staff Profile – Dr David Bennett
1 October 2012
David received his MB PhD qualification from of Guy’s and St Thomas’ Medical School London. He undertook an intercalated PhD studying the role of neurotrophic factors in sensory neuronal development and the generation of persistent pain. Sub-speciality training in neurology took place principally in London at the National Hospital for Neurology and Neurosurgery, King’s College Hospital and Guy’s and St Thomas’ NHS Trust.
London International Youth Science Forum Visits Oxford Neuroscience
1 October 2012
Hosted by Imperial College London, the LIYSF brings together 300 school students from all almost 60 countries for a series of talks, demonstrations, activities and site visits from all areas of the UK’s leading scientific community. 50 students travelled to Oxford for a day of talks and activities focussed on various aspects of neuroscience hosted by Oxford Neuroscience and the Oxford BRC.
Cheltenham Science Festival
29 June 2012
The tenth Cheltenham Science Festival took place between 12th and 17th June. The festival, currently chaired by Oxford’s Professor Russell Foster, brings together some of the World’s most innovative scientists from all fields to engage the public on the science behind today’s news stories, advances and issues.
OCHNCTU – the new name in clinical trials units
19 June 2012
In recognition of the new links with the Nuffield Department of Clinical Neurosciences and the Department of Experimental Psychology, the Oxford Clinical Trials Unit for Mental Illness (OCTUMI) has a new name: the Oxford Cognitive Health and Neuroscience Clinical Trials Unit (OCHNCTU, pronounced oc-n-tü) and a new logo.
Two Wellcome Trust Strategic Awards Confirmed
2 May 2012
Oxford Neurosciences has been successful in gaining two important Wellcome Trust Strategic Awards in the latest round of funding, with a combined value of over £6m. This round had attracted the most applications the Wellcome Trust had ever received, making the success of the applications that much more outstanding.